Healthcare Preview for the Week of: January 29, 2024

McDermott+Consulting
Contact

McDermott+Consulting

Appropriations Process Moves Forward


Over the weekend, negotiators in Congress agreed to certain spending allocations in order to fund various government agencies through most of the year. With both bodies in session this week and deals being made, the appropriations process is moving forward ahead of the March 1 deadline.

This is good news for a potential healthcare package, because it means there may be something to which it can be attached. There is not much overt action on what would be included in this package, but there is some behind-the-scenes movement, which is promising. There is only one healthcare-related hearing on healthcare spending scheduled this week in the House, which will give Energy & Commerce Health subcommittee members an opportunity to voice their priorities and concerns. The Senate Committee on Health, Education, Labor and Pensions executive session on prescription drug costs that was previously scheduled for this week has been cancelled because the pharmaceutical executives agreed to testify at a future hearing without the need for subpoenas.

While Congress inches forward on healthcare, the Administration continues to make progress on several fronts. The Office of Management and Budget (OMB) received the Ensuring Access to Medicaid Services Final Rule today, which means that decisions have been made at the department level around several provisions, including the controversial home- and community-based services payment and transparency proposals. As a reminder, the Medicaid and Children’s Health Insurance Program (CHIP) Managed Care Access, Finance, and Quality Final Rule was already with OMB. Both final rules are expected to be released in April.

Additionally, the Confidentiality of Substance Use Disorder Patient Records Final Rule, commonly referred to as 42 CFR Part 2, has cleared OMB review, so it is expected to be released soon.

The Administration is also making progress regarding artificial intelligence. A US Department of Health and Human Services task force has been established to develop regulations on oversight of the technology and improving equity and nondiscrimination practices by April.

Be sure to regularly check our Election 2024 Resource Center for more information on key topics related to the 2024 election and its impact on health policymaking.

[View source.]

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© McDermott+Consulting | Attorney Advertising

Written by:

McDermott+Consulting
Contact
more
less

McDermott+Consulting on:

Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:
*By using the service, you signify your acceptance of JD Supra's Privacy Policy.
Custom Email Digest
- hide
- hide